Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2023-09, Vol.55, p.S223
Main Authors: Gabbia, D., Zanotto, I., Frion-Herrera, Y., De Rossi, A., Grigoletto, A., Pasut, G., De Martin, S.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1590-8658
DOI:10.1016/j.dld.2023.08.028